Search for: "W' Care, LLC" Results 241 - 260 of 267
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2014, 5:52 am
APP Pharmaceuticals, LLC, 2013 WL 5532767, at *7-8 (D. [read post]
10 Sep 2011, 12:59 am
Upon review, the Tenth Circuit affirmed the grants of summary judgment on the dormant Commerce Clause and preemption issues, and the dismissals based on standing and ripeness: [w]e hold that the Red River Compact insulates Oklahoma water statutes from dormant Commerce Clause challenge insofar as they apply to surface water subject to the Compact. [read post]
18 Jul 2014, 11:55 am
 Why not, under Huck's theory, if it is foreseeable others will copy the design? [read post]
21 Nov 2011, 1:50 pm by Geoffrey Rapp
Couvillion, Note, Defending for its life: ChampionsWorld LLC v. [read post]
27 Mar 2009, 7:20 am
(Ip's What's Up)   Africa New US Trade Representative - Afro implications (Afro-IP)   Argentina Official collective management organisation for film directors (IP tango)   Asia An Asian perspective on the credit crunch (Managing Intellectual Property)   Canada Scotch Whisky Association seeks leave to appeal FCA decision to the Supreme Court in trade mark battle over GLEN (Excess Copyright)   China Third revision of… [read post]
25 Apr 2012, 1:14 pm by Steven G. Pearl
 In other words, the trial court did not abuse its discretion by postponing a legal decision on the obligation to provide meal and rest periods, and it may not have abused its discretion by determining those issues at the certification stage, but courts should be very careful about making such determinations before certification. [read post]
19 Jul 2012, 4:07 pm by Schachtman
Conn. 2010) (“The court concludes that it was not necessary for the [expert witness's] initial regression analysis to be contained in the [expert] report” that was disclosed pursuant to Rule 26(a)(2)). [read post]
9 Dec 2015, 6:50 am
Bograd, “Be Careful What You Wish for:  Drugmakers, the First Amendment, & Preemption,” 51 Trial 24 (Nov. 2015). [read post]
8 May 2009, 10:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: USTR releases Special 301 Report ‘Priority Watch List’ (Public Knowledge) (Intellectual Property Watch) (Patent Docs) (I/P Updates) (IP Dragon) (Afro-IP) (Michael Geist) (Excess Copyright) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Ars Technica) (At Last... the 1709… [read post]
9 Oct 2015, 12:15 pm by John Elwood
  First, “[w]hether the Federal Circuit improperly abrogated the plain meaning of 35 U.S.C. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
14 Nov 2014, 5:42 am by John Elwood
Food Lion, LLC, 14-110, has now been rescheduled a second time. [read post]
30 Jan 2009, 7:00 pm
(Patent Prospector)   US Patents Congress weighs patent specialisation for federal judges (Ars Technica) (Inventive Step) (Law360) (IP Spotlight) (Patent Prospector) M Lemley & B Sampat’s report ‘Examiner Characteristics and the Patent Grant Rate’ – experienced examiners allow more, cite less (Peter Zura's 271 Patent Blog) PTO problems are not new; the more things change, the more they stay the same (Inventive Step) Peer to… [read post]